121 related articles for article (PubMed ID: 35385727)
1. NADPH metabolism determines the leukemogenic capacity and drug resistance of AML cells.
Chen C; Lai X; Zhang Y; Xie L; Yu Z; Dan S; Jiang Y; Chen W; Liu L; Yang Y; Huang D; Zhao Y; Zheng J
Cell Rep; 2022 Apr; 39(1):110607. PubMed ID: 35385727
[TBL] [Abstract][Full Text] [Related]
2. Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells.
Huang D; Zhang C; Xiao M; Li X; Chen W; Jiang Y; Yuan Y; Zhang Y; Zou Y; Deng L; Wang Y; Sun Y; Dong W; Zhang Z; Xie L; Yu Z; Chen C; Liu L; Wang J; Yang Y; Yang J; Zhao Y; Zheng J
Proc Natl Acad Sci U S A; 2023 Mar; 120(13):e2210796120. PubMed ID: 36947513
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models.
He X; Wan J; Yang X; Zhang X; Huang D; Li X; Zou Y; Chen C; Yu Z; Xie L; Zhang Y; Liu L; Li S; Zhao Y; Shao H; Yu Y; Zheng J
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33301426
[TBL] [Abstract][Full Text] [Related]
4. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Imaging Reveals a Unique Preference of Symmetric Cell Division and Homing of Leukemia-Initiating Cells in an Endosteal Niche.
Hao X; Gu H; Chen C; Huang D; Zhao Y; Xie L; Zou Y; Shu HS; Zhang Y; He X; Lai X; Zhang X; Zhou BO; Zhang CC; Chen GQ; Yu Z; Yang Y; Zheng J
Cell Metab; 2019 Apr; 29(4):950-965.e6. PubMed ID: 30581117
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche.
Wang Y; Sun X; Yuan S; Hou S; Guo T; Chu Y; Pang T; Luo HR; Yuan W; Wang X
Cytotherapy; 2020 Mar; 22(3):127-134. PubMed ID: 32024607
[TBL] [Abstract][Full Text] [Related]
7. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia.
Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J
Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911
[TBL] [Abstract][Full Text] [Related]
8. Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy.
Haladyna JN; Pastuer T; Riedel SS; Perraud AL; Bernt KM
Exp Hematol; 2016 Jul; 44(7):596-602.e3. PubMed ID: 27033163
[TBL] [Abstract][Full Text] [Related]
9. AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow.
Saito Y; Chapple RH; Lin A; Kitano A; Nakada D
Cell Stem Cell; 2015 Nov; 17(5):585-96. PubMed ID: 26440282
[TBL] [Abstract][Full Text] [Related]
10. P2X1 enhances leukemogenesis through PBX3-BCAT1 pathways.
He X; Xu Y; Huang D; Yu Z; Yu J; Xie L; Liu L; Yu Y; Chen C; Wan J; Zhang Y; Zheng J
Leukemia; 2023 Feb; 37(2):265-275. PubMed ID: 36418376
[TBL] [Abstract][Full Text] [Related]
11. WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target.
Zhou B; Jin X; Jin W; Huang X; Wu Y; Li H; Zhu W; Qin X; Ye H; Gao S
J Transl Med; 2020 Jun; 18(1):254. PubMed ID: 32580769
[TBL] [Abstract][Full Text] [Related]
12. [Role of Vascular Niche of Bone Marrow in the Development of MLL-AF9 Induced Acute Myclaid Leukemia].
Zhao M; Gong YM; Yang WZ; Cheng H; Cheng T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):318-326. PubMed ID: 30998132
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
14. Ferredoxin/thioredoxin system plays an important role in the chloroplastic NADP status of Arabidopsis.
Hashida SN; Miyagi A; Nishiyama M; Yoshida K; Hisabori T; Kawai-Yamada M
Plant J; 2018 Sep; 95(6):947-960. PubMed ID: 29920827
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
[TBL] [Abstract][Full Text] [Related]
16. TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia.
Wang N; Guo D; Zhao YY; Dong CY; Liu XY; Yang BX; Wang SW; Wang L; Liu QG; Ren Q; Lin YM; Ma XT
Oncotarget; 2015 Aug; 6(25):20977-92. PubMed ID: 26023795
[TBL] [Abstract][Full Text] [Related]
17. ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia.
Wang Y; Skibbe JR; Hu C; Dong L; Ferchen K; Su R; Li C; Huang H; Weng H; Huang H; Qin X; Jin J; Chen J; Jiang X
Sci Rep; 2017 May; 7(1):1853. PubMed ID: 28500307
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
19. Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia.
Di Marcantonio D; Martinez E; Sidoli S; Vadaketh J; Nieborowska-Skorska M; Gupta A; Meadows JM; Ferraro F; Masselli E; Challen GA; Milsom MD; Scholl C; Fröhling S; Balachandran S; Skorski T; Garcia BA; Mirandola P; Gobbi G; Garzon R; Vitale M; Sykes SM
Clin Cancer Res; 2018 Feb; 24(3):608-618. PubMed ID: 29127121
[No Abstract] [Full Text] [Related]
20. SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation.
Ma J; Liu B; Yu D; Zuo Y; Cai R; Yang J; Cheng J
Br J Haematol; 2019 Oct; 187(1):49-64. PubMed ID: 31236919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]